Venus Remedies Ltd, a leading pharmaceutical company, announced that it has obtained approvals to market two important oncology medications (carboplatin and bortezomib) in Morocco and the Philippines. "These approvals are pivotal in our...
Boston Scientific Corporation, a leading company in the field of global medical technology, stated that it has been granted approval by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the FARAPULSE Pulsed Field Ablation (PFA)...
Drug manufacturer Dr Reddy's Laboratories Ltd has invested $620 million into its wholly-owned branch, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment is consistent with the company's previous board-approved decision to invest up...
CSIR-Central Drug Research Institute (CDRI), an esteemed research institute in the field of biomedicine, has revealed a partnership with Blockchain For Impact (BFI) to participate in the BFI-BIOME Virtual Network Programme. This partnership will...
Tagrisso (osimertinib) from AstraZeneca has been given the approval in the US to treat adult patients with unresectable, Stage III EGFRm NSCLC who have not seen their disease worsen after platinum-based CRT. Tagrisso is approved for individuals...
The World Health Organization (WHO) issued guidance on how to enhance the organization and supervision of clinical trials in nations with diverse income levels. This guidance seeks to enhance country-led R&D ecosystems in order to progress health...
Sklepios BioPharmaceutical (AskBio), has formed a strategic alliance with Belief BioMed in China to further the progress of innovative gene therapies. The goal of the collaboration is to take advantage of the experience of both companies in gene...
MediBuddy, the biggest digital healthcare platform in India, has partnered with Philips, a global leader in health technology, to transform preventive healthcare in India. For World Heart Day on September 29, the collaboration will provide heart...
MedGenome, a prominent worldwide genomics-focused diagnostics and research services company, is joining forces with Twist Bioscience, a fast-growing synthetic biology and genomics company in the US, to create the HOPE for Rare Diseases Programme...
PreAnalytiX GmbH, formed by QIAGEN N.V. and BD, has introduced the PAXgene Urine Liquid Biopsy Set for analyzing cell-free DNA in urine using various molecular testing technologies like qPCR, digital PCR, and NGS. QIAGEN will commercialize the new...
, CDSCO.jpg)
